Learn how TLS partnered with an investigational drug asset-holder to develop a fully digital protocol in a rare disease.
Learn how TLS partnered with a large pharmaceutical company to design and execute a pilot study of telemedicine in ulcerative colitis.
Transparency Life Sciences is a leader in digital drug development services offering virtual and hybrid clinical trials. Our protocol crowdsourcing software and mobile health technology enable drug candidates to advance through clinical trials with unprecedented patient convenience, data relevance, efficiency and affordability.
Always stay in the loop.
Sign up for our latest updates.